FBEL Bel SA

Bel: share buyback tender offer

Bel: share buyback tender offer

Bel adjusts its capital allocation and funding strategy and

decides not to file a draft public share buyback tender offer (“OPRA”)

Suresnes, 30 September 2021

Since Bel’s 19 March 2021 announcement of its intention to file a public share buyback tender offer (“OPRA”) at €440 per share, the Group has successfully pursued its transformation strategy including progress on its plan to sell Leerdammer1. Implementation of said strategy also resulted in an acceleration of its investments in promising market segments and geographies notably through the exercise of its call option on a 17.56% equity stake in MOM Group and pursuing R&D investment in order to cement the Group’s leadership in healthy snacking, primarily by building its offering on the three complementary market segments - dairy, fruit and plant-based.

Bel has furthermore been informed of Unibel’s decision to increase the price of its draft public buy-out tender offer followed by a squeeze-out (“OPR-RO”) at €550 per Bel share. Said price represents a 45.5% premium over the 17 March 20212 closing share price, 58.4% over the volume-weighted average share price during the 60 days prior to 17 March 2021 (included) and 25% over the €440 price announced on 19 March 2021.

In a context of acceleration of investment efforts combined with a difficult economic and geopolitical situation in the Middle East and North Africa since first half 2021, Bel Group has decided to adjust its strategy and not to file the OPRA.

About Bel

The Bel Group is a world leader in branded cheese and a major player in the healthy snack market. Its portfolio of differentiated and internationally recognized brands include such products as The Laughing Cow®, Kiri®, Mini Babybel®, Boursin®, Pom’Potes®, and GoGo squeeZ®, as well as some 20 local brands. Together, these brands helped the Group generate sales of €3.46 billion in 2020.

12,510 employees in some 40 subsidiaries around the world contribute to rolling out the Group's mission to champion healthier and responsible food for everyone. Bel products are made at 33 production sites and distributed in nearly 120 countries.

Media Relations

Havas Paris - Sarah Duparc

- 01.58.47.82.06 / 06.46.72.39.99


1        Transfer by Sicopa, a wholly-owned Bel subsidiary, of a business comprising Royal Bel Leerdammer NL, Bel Italia, Bel Deutschland, the brand Leerdammer and all related rights, plus Bel Shostka Ukraine in return for 1,591,472 Bel shares (23.16% equity stake) held by Lactalis.

2        The day before the announcement of Bel and Lactalis Group entering into exclusive talks to sell a business comprising Royal Bel Lambda NL, Bel Italia, Bel Deutschland, the brand Leerdammer and all related rights, plus Bel Shostka Ukraine.

Attachment



EN
30/09/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bel SA

Delphine Chauvin
  • Delphine Chauvin

Bel : Issuance Focus

Bel group has launched the placement of a € 300m to € 500m bond maturing in 2029 (five years), which will be used in particular to begin refinancing the schuldshein maturities scheduled to start next year. We are adopting a Stable credit opinion. Overall, we have no major concerns about the group's financial position. Management has always demonstrated cautious approach, and current credit ratios reflect a moderately leveraged financial position (a net debt/EBITDA ratio of 2...

Delphine Chauvin
  • Delphine Chauvin

Bel : Focus Emission

Le groupe Bel lance le placement d’une obligation de 300 à 500 m EUR à échéance 2029 (5 ans) qui servira notamment à commencer à refinancer les échéances de schuldshein prévues à partir de l’année prochaine. Nous adoptons un Avis Crédit Stable. Dans l’ensemble, nous ne relevons pas de points d’inquiétudes majeurs sur l’évolution de la situation financière du groupe. Le management a fait toujours fait preuve d’une gestion prudente et les ratios de crédit actuels témoignent d’...

 PRESS RELEASE

Bel : First-Half 2023 Financial Information Sales and Results

Bel : First-Half 2023 Financial Information Sales and Results Suresnes – July 27, 2023, at 6 p.m. BelFirst-Half 2023 Financial InformationSales and Results Solid performance in a persistent inflationary environment H1 consolidated sales totaled €1.8 bn, representing organic growth of 9.1%1 and an increase of 6.3% on a reported basis: Solid gains by the fruit segment2 in all geographies.Accelerating growth in China and positive trends in North America.Good performances from core cheese brands such as Kiri® and Boursin®.Healthy momentum in e-commerce and out-of-home (OOH) distribution cha...

 PRESS RELEASE

BEL : Information financière du 1er semestre 2023 Chiffre d’affaires e...

BEL : Information financière du 1er semestre 2023 Chiffre d’affaires et résultats Suresnes, le 27 juillet 2023 – 18h00 BelInformation financière du 1er semestre 2023Chiffre d’affaires et résultats Performance solidedans un contexte inflationniste persistant Chiffre d’affaires semestriel à 1,8 Md€, en croissance organique de + 9,1 %1 et en progression de +6,3 % en données publiées : Solide croissance de l’activité fruit2 sur l’ensemble des géographies.Accélération de la croissance en Chine et tendance positive en Amérique du Nord.Bonne performance des marques cœur fromagères, notamment K...

 PRESS RELEASE

BEL : Communiqué de presse - Décision Cour de cassation

BEL : Communiqué de presse - Décision Cour de cassation Suresnes, le 16 mars 2023, 18h00 Bel La Cour de cassation confirme la décision de la Cour d’appel de Paris et donne raison à Unibel et Bel dans le cadre du différend, les opposant à la société BBDE SAS, relatif à l’offre publique de retrait d’Unibel sur Bel suivie d’un retrait obligatoire Dans la droite ligne de la décision de la Cour d’appel de Paris du 12 mai 2022 rejetant le recours de la société BBDE, la Cour de cassation confirme en tout point la position de la Cour d’appel par son arrêt en date du 15 mars 2023. Il est rappelé...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch